Sam68 Allows Selective Targeting of Human Cancer Stem Cells

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Targeting cancer stem cells (CSCs) is crucial for effective cancer therapy.
• Identifying CSC-specific vulnerabilities is challenging as key pathways, like Wnt/β-catenin signaling, are also vital for healthy stem cells (SCs).
• The Wnt/β-catenin pathway plays a dual role in both cancer progression and normal stem cell regulation.

Purpose of the Study:

• To identify unique vulnerabilities in human cancer stem cells (CSCs) compared to healthy resident stem cells (SCs).
• To investigate the role of Sam68 in modulating Wnt/β-catenin signaling specifically within CSCs.
• To explore the therapeutic potential of targeting Sam68-CBP interactions for cancer treatment.

Main Methods:

• Utilized small molecules ICG-001 and CWP to disrupt CBP-β-catenin interactions.
• Investigated the formation of a Sam68-CBP complex in CSCs.
• Assessed the downstream effects on Wnt signaling, inducing apoptosis and differentiation.

Main Results:

• Sam68 acts as a previously unrecognized modulator of Wnt/β-catenin signaling in human CSCs.
• Disruption of CBP-β-catenin interaction by ICG-001/CWP leads to Sam68-CBP complex formation in CSCs.
• This complex formation alters Wnt signaling, promoting CSC apoptosis and differentiation.

Conclusions:

• Sam68 is identified as a key regulator of human CSC vulnerability.
• Targeting the Sam68-CBP interaction presents a novel therapeutic strategy for selectively eliminating CSCs.
• This approach may overcome the challenge of targeting CSCs without harming healthy stem cells.